122 related articles for article (PubMed ID: 16197890)
1. [Progressive multifocal leukoencephalopathy after natalizumab therapy].
Schmitt C; Bensussan A
Med Sci (Paris); 2005 Oct; 21(10):797-8. PubMed ID: 16197890
[No Abstract] [Full Text] [Related]
2. Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.
Berger T; Deisenhammer F
N Engl J Med; 2005 Oct; 353(16):1744-6; author reply 1744-6. PubMed ID: 16236749
[No Abstract] [Full Text] [Related]
3. Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma.
Kranick SM; Mowry EM; Rosenfeld MR
Neurology; 2007 Aug; 69(7):704-6. PubMed ID: 17698796
[No Abstract] [Full Text] [Related]
4. Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.
Berger JR; Koralnik IJ
N Engl J Med; 2005 Jul; 353(4):414-6. PubMed ID: 15947082
[No Abstract] [Full Text] [Related]
5. Natalizumab for relapsing multiple sclerosis.
Jeffery DR
N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16742008
[No Abstract] [Full Text] [Related]
6. Balancing risk and reward: the question of natalizumab.
Hauser SL; Johnston SC
Ann Neurol; 2009 Sep; 66(3):A7-8. PubMed ID: 19810091
[No Abstract] [Full Text] [Related]
7. Natalizumab and progressive multifocal leukoencephalopathy.
Adelman B; Sandrock A; Panzara MA
N Engl J Med; 2005 Jul; 353(4):432-3. PubMed ID: 15947083
[No Abstract] [Full Text] [Related]
8. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.
Wenning W; Haghikia A; Laubenberger J; Clifford DB; Behrens PF; Chan A; Gold R
N Engl J Med; 2009 Sep; 361(11):1075-80. PubMed ID: 19741228
[TBL] [Abstract][Full Text] [Related]
9. [Natalizumab in multiple sclerosis: unclear patient benefits].
Schipper JP
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):852-5. PubMed ID: 17472115
[TBL] [Abstract][Full Text] [Related]
10. Interruption of natalizumab therapy for multiple sclerosis: what are the risks?
Naismith RT; Bourdette D
Neurology; 2011 May; 76(22):1854-5. PubMed ID: 21543735
[No Abstract] [Full Text] [Related]
11. [Natalizumab in multiple sclerosis].
Rajda C; Bencsik K; Vécsei L;
Ideggyogy Sz; 2008 May; 61(5-6):204-8. PubMed ID: 18567397
[No Abstract] [Full Text] [Related]
12. PML risk and natalizumab: more questions than answers.
Ransohoff RM
Lancet Neurol; 2010 Mar; 9(3):231-3. PubMed ID: 20117056
[No Abstract] [Full Text] [Related]
13. Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
Vennegoor A; Wattjes MP; van Munster ET; Kriekaart RL; van Oosten BW; Barkhof F; Killestein J; Polman CH
Neurology; 2011 Feb; 76(6):574-6. PubMed ID: 21300973
[No Abstract] [Full Text] [Related]
14. Natalizumab and progressive multifocal leucoencephalopathy.
Berger JR
Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii48-53. PubMed ID: 17038473
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.
Van Assche G; Van Ranst M; Sciot R; Dubois B; Vermeire S; Noman M; Verbeeck J; Geboes K; Robberecht W; Rutgeerts P
N Engl J Med; 2005 Jul; 353(4):362-8. PubMed ID: 15947080
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy after natalizumab monotherapy.
Lindå H; von Heijne A; Major EO; Ryschkewitsch C; Berg J; Olsson T; Martin C
N Engl J Med; 2009 Sep; 361(11):1081-7. PubMed ID: 19741229
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.
Alvarez-Cermeño JC; Masjuan J; Villar LM
N Engl J Med; 2005 Oct; 353(16):1744-6; author reply 1744-6. PubMed ID: 16240475
[No Abstract] [Full Text] [Related]
18. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.
Langer-Gould A; Atlas SW; Green AJ; Bollen AW; Pelletier D
N Engl J Med; 2005 Jul; 353(4):375-81. PubMed ID: 15947078
[TBL] [Abstract][Full Text] [Related]
19. Natalizumab for relapsing multiple sclerosis.
Tenser RB
N Engl J Med; 2006 Jun; 354(22):2387-9; author reply 2387-9. PubMed ID: 16738278
[No Abstract] [Full Text] [Related]
20. [New drugs; natalizumab].
van Bronswijk H; Dubois EA; van Gerven JM; Cohen AF
Ned Tijdschr Geneeskd; 2008 Mar; 152(9):499-500. PubMed ID: 18389881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
